Effects of pharmaceutical price regulation: China's evidence between 1997 and 2008
Effects of pharmaceutical price regulation: China's evidence between 1997 and 2008
复制标题
药品价格管制的影响：1997年至2008年中国的证据
DOI：
10.1080/13547860.2014.964968
复制
发表时间：
2015
影响因子：
1.4
通讯作者：
Qiao Xue
中科院分区：
文献类型：
--
作者：
Wu Binzhen;Zhang Qiong;Qiao Xue
本文采用1997 - 2008年的宏观数据，对我国药品价格管制的效果进行了评价。我们发现，法规对药品价格指数产生短期影响，使其下降不到0.5个百分点。如果对更多的药品实行价格管制，效果可能会略有加强。价格法规未能减少家庭医疗支出和制药行业的平均盈利能力。此外，处于盈亏平衡点的公司在实施后情况更糟。最后，虽然这些条例对医药替代品或补充品的价格没有重大影响，但却增加了昂贵药品的进口。根据2008年进行的家庭调查数据，这些结果也与消费者对药品政策的看法一致。
This study uses a macro-level data during the period between 1997 and 2008 to evaluate the effects of China's pharmaceutical price regulations. We find that the regulations exert short-run effects on pharmaceutical price indexes, reducing them by less than 0.5 percentage points. The effects can be slightly reinforced if the price regulations were to be applied to more medicines. The price regulations fail to reduce household health expenditures and the average profitability of the pharmaceutical industry. Moreover, firms on the break-even point are worse off after the implementation. Finally, although these regulations have no significant effects on the prices of medicinal substitutes or complements, they increase the importation of expensive medicines. These findings are also consistent with consumer perceptions of the pharmaceutical policies, based on the household survey data conducted in 2008.